Implementation of virtual waiting room technology enabled a record 438 patients added to the pipeline, up 54% over Q1 2022
Advertising efficiencies resulted in cost per pipeline add of $1,579, down 50% sequentially
Conference call begins at 4:30 p.m. Eastern time today
BOSTON (May 10, 2023) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three months ended March 31, 2023. Read more.